How does estrogen protect bones? Unraveling a pathway to menopausal bone loss

March 22, 2019

Researchers at Tokyo Medical and Dental University (TMDU) and The University of Tokyo find a connection between estrogen and bone health that may offer a new way to treat osteoporosis in women experiencing menopause

Tokyo-Osteoporosis is a condition in which bones become weak and prone to fractures. Fractures typically occur in the wrist, spine, or hip, and can often lead to permanently impaired mobility. Women over 50 are at a high risk of developing osteoporosis, which may be due to the loss of estrogen that occurs after menopause. While studies have linked estrogen levels to bone health, the exact details of this connection are not entirely clear. Researchers at Tokyo Medical and Dental University (TMDU) describe a new molecular link between estrogen and bone aging, which may eventually lead to new strategies to treat postmenopausal osteoporosis.

Bone is a complex tissue, consisting of a matrix of proteins and minerals that give it the flexibility and strength to support body movement. Bone also contains several types of specialized cells, including osteocytes, that help to maintain this matrix. Over a person's lifetime, many factors can affect how healthy bone structure is maintained. One of these factors is the female sex hormone, estrogen.

"Over the last few decades, we've learned that estrogen plays an important role in maintaining a functional bone matrix," corresponding authors Tomoki Nakashima and Hiroshi Takayanagi explain. "Exactly how estrogen does this, though, is not fully understood. Our laboratory recently discovered that bone matrix is maintained by a protein called Sema3A, which is secreted by osteocytes. This led us to suspect that there might be a mechanistic relationship between estrogen and Sema3A."

Sema3A does indeed appear to be linked to estrogen: the researchers found that blood serum levels of the protein decrease in premenopausal women as they get older--and drop even further once women reach menopause. But how, at the biological level, are estrogen and Sema3A related? And what is Sema3A doing in bone tissue?

To answer these questions, the researchers turned to mice. When mice are given an ovariectomy (that is, when their ovaries are removed), the loss of estrogen causes their bone mass to decrease. This can be prevented, however, by giving the mice an extra supply of the hormone. The team took advantage of this to explore the function of Sema3A.

"When we genetically removed Sema3A from the osteoblast lineage cells (including osteocytes) of mice, we found that intravenous estrogen no longer prevented bones from deteriorating after an ovariectomy," lead author Mikihito Hayashi describes. "In addition, we found that Sema3A sets off a chain of signaling events that promote the survival of osteocytes in these mice. This suggests that Sema3A serves as a key mechanistic link between estrogen and bone maintenance .

We believe that, as women lose estrogen with age and Sema3A levels drop off, osteocytes begin to die and bone loses the ability to maintain its supportive structure."

The researchers hope that the discovery of Sema3A as a major player in bone health and the signaling molecules it controls in bone may offer new therapeutic approaches to treating osteoporosis.
-end-
The article, "Autoregulation of osteocyte Sema3A orchestrates estrogen action and counteracts bone aging" was published in Cell Metabolism at DOI: 10.1016/j.cmet.2018.12.021.

Tokyo Medical and Dental University

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.